iFIT Seminar Series Session with Tuomas Tammela, PhD
Functional interrogation of intra-tumoral heterogeneity in distinct physiological contexts
On behalf of the iFIT spokespersons Lars Zender, Juliane Walz and Bernd Pichler, it is our pleasure to inform you about and invite you to the next iFIT Seminar Series Session 2024 that will take place
on Tuesday, October 1st at 2:20 pm (CEST)
at Big Lecture Hall 210 in the CRONA Clinics (CRONA Kliniken, Hoppe-Seyler-Straße 3, 72076 Tübingen).
Our guest speaker, Tuomas Tammela, PhD (Memorial Sloan Kettering Cancer Center, New York City, USA) will give a talk on
Functional interrogation of intra-tumoral heterogeneity in distinct physiological contexts.
Dr. Tammela earned his M.D. and Ph.D. from the University of Helsinki, Finland, where he worked in the laboratory of Prof. Kari Alitalo, studying molecular mechanisms that control blood and lymphatic vessels growth. Dr. Tammela then moved to MIT for postdoctoral training with Prof. Tyler Jacks. During this time, he became interested in cellular heterogeneity in cancer and identified cancer-derived niches as drivers of stem-like cells in lung cancer. Dr. Tammela joined the faculty at Memorial Sloan Kettering Cancer Center in 2017 and is currently an Associate Member in the Cancer Biology & Genetics Program at the Sloan Kettering Institute. The Tammela Lab studies phenotypic heterogeneity of cancer cells within tumors using genetically engineered mouse models, single cell approaches, tracing and ablation of distinct tumor cell lineages, CRISPR-mediated gene regulation, and advanced imaging techniques. The overarching goal of these efforts is to discover pathways that drive distinct cellular phenotypes and to develop new therapeutic concepts aimed at reducing cellular heterogeneity in tumors. In addition, emerging efforts in the Tammela laboratory focus on how aging and other changes in organismal physiology impact cancer evolution. Dr. Tammela holds scholarships from the American Cancer Society, the Josie Robertson Foundation, the Rita Allen Foundation and the V Foundation. He is a recipient of a Mark Foundation Emerging Leader Award, an NIH-NCI R37 MERIT Award, an AACR Next Generation Transformative Research Award, and the Werner Risau Prize.
As a special feature of this program, the iFIT will sponsor free lunch packages! (First come, first serve)
All members of the University Hospital and University of Tübingen are invited to participate!
We look forward to this Seminar Series session and to see you there!
